News

The stock's market-beating momentum has come crashing to a halt, following shocking allegations from one of the world's largest pharmaceutical companies.
Novo Nordisk is seen as having fallen behind in the race for new obesity drugs. It argues it is playing the long game.
Beyond the Scale” focuses on obesity as a chronic disease - urging empathy, early intervention, and evidence-based care.
Results from the Phase IIIb FRONTIER5 trial demonstrated that Mim8 prophylaxis was well-tolerated when administered without a ...
Danish drugmaker Novo Nordisk on Tuesday launched its blockbuster weight-loss drug Wegovy in India, three months after Eli ...